UK Trial Tests Drugs for 'Broken Heart' Condition

A groundbreaking seven-year study is underway across the UK to find effective treatments for takotsubo cardiomyopathy, commonly known as broken heart syndrome. This condition, which affects thousands annually, primarily women, mimics heart attack symptoms such as chest pain and breathlessness but is triggered by intense emotional or physical stress.

Brenda Young, a 57-year-old from Aberdeenshire, experienced this syndrome after her mother's passing last November. Initially suspected as a heart attack, her diagnosis was takotsubo cardiomyopathy. She hopes the new medication trial will provide relief and increase awareness of the syndrome.

The University of Aberdeen is leading the trial, involving nearly 1,000 patients from 40 hospitals. Scientists will assess if renin-angiotensin system (RAS) inhibitors, drugs that relax blood vessels, can effectively treat the condition. This marks the first time these medications will be tested for long-term impact on takotsubo syndrome.

Professor Dana Dawson, leading the trial, highlighted that while diagnostic rates have increased, there are currently no proven therapies for takotsubo syndrome. The study aims to potentially discover the first effective treatment, improving survival rates and the quality of life for patients who often experience debilitating symptoms. Researchers are also exploring collaborations for the study in Australia.